Dentsply Intl (XRAY) Holder Tirschwell & Loewy Upped Position; As Endo Intl Plc (ENDP) Market Value Declined, Holder Pointstate Capital LP Increased Position

January 4, 2018 - By wolcottdaily

Tirschwell & Loewy Inc increased its stake in Dentsply Intl (XRAY) by 2.13% based on its latest 2017Q3 regulatory filing with the SEC. Tirschwell & Loewy Inc bought 5,187 shares as the company’s stock declined 1.69% while stock markets rallied. The institutional investor held 248,398 shares of the medical and dental instruments company at the end of 2017Q3, valued at $14.86 million, up from 243,211 at the end of the previous reported quarter. Tirschwell & Loewy Inc who had been investing in Dentsply Intl for a number of months, seems to be bullish on the $15.37B market cap company. The stock decreased 0.01% or $0.01 during the last trading session, reaching $66.9. About 634,588 shares traded. DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has risen 2.17% since January 4, 2017 and is uptrending. It has underperformed by 14.53% the S&P500.

Pointstate Capital Lp increased its stake in Endo Intl Plc (ENDP) by 5892.62% based on its latest 2017Q3 regulatory filing with the SEC. Pointstate Capital Lp bought 3.83M shares as the company’s stock declined 9.17% while stock markets rallied. The hedge fund held 3.90M shares of the major pharmaceuticals company at the end of 2017Q3, valued at $33.36M, up from 65,000 at the end of the previous reported quarter. Pointstate Capital Lp who had been investing in Endo Intl Plc for a number of months, seems to be bullish on the $1.94 billion market cap company. The stock decreased 1.81% or $0.16 during the last trading session, reaching $8.7. About 3.47M shares traded. Endo International plc (NASDAQ:ENDP) has declined 19.57% since January 4, 2017 and is downtrending. It has underperformed by 36.27% the S&P500.

Among 19 analysts covering Dentsply International (NASDAQ:XRAY), 14 have Buy rating, 1 Sell and 4 Hold. Therefore 74% are positive. Dentsply International had 47 analyst reports since August 3, 2015 according to SRatingsIntel. The rating was maintained by Morgan Stanley with “Overweight” on Thursday, August 10. On Friday, September 15 the stock rating was maintained by Robert W. Baird with “Buy”. The firm has “Buy” rating by H.C. Wainwright given on Monday, November 6. Morgan Stanley downgraded DENTSPLY SIRONA Inc. (NASDAQ:XRAY) on Thursday, March 24 to “Equal-Weight” rating. The firm has “Neutral” rating by JP Morgan given on Thursday, September 22. The stock of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) earned “Sell” rating by Goldman Sachs on Tuesday, May 23. The firm has “Buy” rating given on Friday, September 18 by Northcoast. The firm has “Buy” rating by Stifel Nicolaus given on Tuesday, October 17. The rating was maintained by Jefferies on Friday, October 20 with “Buy”. The rating was initiated by Piper Jaffray with “Overweight” on Monday, June 13.

Investors sentiment increased to Infinity in Q3 2017. Its up Infinity, from 4 in 2017Q2. It is positive, as 0 investors sold XRAY shares while 0 reduced holdings. 1 funds opened positions while 5 raised stakes. 812,996 shares or 4.27% more from 779,672 shares in 2017Q2 were reported. 248,398 were reported by Tirschwell & Loewy Incorporated. Burney Communications has 0.02% invested in DENTSPLY SIRONA Inc. (NASDAQ:XRAY). Gemmer Asset Mngmt Limited Com owns 252 shares. Cibc World Mkts reported 0.03% of its portfolio in DENTSPLY SIRONA Inc. (NASDAQ:XRAY). Cardinal Mngmt owns 1.37% invested in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) for 72,544 shares. West Oak Limited Com has invested 0.82% in DENTSPLY SIRONA Inc. (NASDAQ:XRAY). Eqis Cap Inc has invested 0.02% in DENTSPLY SIRONA Inc. (NASDAQ:XRAY).

Tirschwell & Loewy Inc, which manages about $679.14M and $661.33 million US Long portfolio, decreased its stake in Kraft Heinz Co. by 9,600 shares to 5,225 shares, valued at $405,000 in 2017Q3, according to the filing. It also reduced its holding in Occidental Pete Corp Cal (NYSE:OXY) by 26,275 shares in the quarter, leaving it with 6,064 shares, and cut its stake in Schlumberger Limited (NYSE:SLB).

Investors sentiment decreased to 1.12 in Q3 2017. Its down 0.11, from 1.23 in 2017Q2. It dropped, as 31 investors sold ENDP shares while 64 reduced holdings. 21 funds opened positions while 85 raised stakes. 202.81 million shares or 2.30% more from 198.25 million shares in 2017Q2 were reported. Asset Inc accumulated 10,317 shares or 0% of the stock. Prudential Financial Inc reported 0.06% stake. Ny State Teachers Retirement Sys accumulated 295,713 shares or 0.01% of the stock. Bluemountain Cap Mgmt Ltd Liability Corporation accumulated 99,523 shares. Commerzbank Aktiengesellschaft Fi holds 459,601 shares. United Kingdom-based Barclays Public Ltd Co has invested 0% in Endo International plc (NASDAQ:ENDP). Jane Street Grp Incorporated Ltd Llc stated it has 61,070 shares. Moors & Cabot reported 10,400 shares stake. Oregon Public Employees Retirement Fund holds 73,204 shares or 0.01% of its portfolio. Aperio Group Lc holds 0% in Endo International plc (NASDAQ:ENDP) or 31,069 shares. Nomura Holding invested in 0% or 18,123 shares. Gotham Asset Mngmt Ltd Liability Corp reported 0.15% of its portfolio in Endo International plc (NASDAQ:ENDP). 259,505 are held by Jacobs Levy Equity Mngmt. Mason Street Advisors Limited Com holds 0.02% of its portfolio in Endo International plc (NASDAQ:ENDP) for 99,745 shares. Bogle Inv LP De has 0.92% invested in Endo International plc (NASDAQ:ENDP).

Among 22 analysts covering Endo International plc (NASDAQ:ENDP), 7 have Buy rating, 1 Sell and 14 Hold. Therefore 32% are positive. Endo International plc had 80 analyst reports since August 11, 2015 according to SRatingsIntel. The stock of Endo International plc (NASDAQ:ENDP) has “Buy” rating given on Tuesday, January 31 by Mizuho. As per Friday, November 6, the company rating was maintained by Deutsche Bank. The stock has “Outperform” rating by Leerink Swann on Tuesday, August 11. Guggenheim initiated the shares of ENDP in report on Friday, June 16 with “Hold” rating. Oppenheimer reinitiated the stock with “Perform” rating in Wednesday, December 7 report. The stock of Endo International plc (NASDAQ:ENDP) earned “Hold” rating by Cantor Fitzgerald on Tuesday, August 8. Cowen & Co maintained Endo International plc (NASDAQ:ENDP) rating on Tuesday, August 8. Cowen & Co has “Hold” rating and $1600 target. The stock has “Hold” rating by Cowen & Co on Thursday, November 9. Stifel Nicolaus maintained the shares of ENDP in report on Friday, October 20 with “Hold” rating. The rating was maintained by Citigroup with “Buy” on Friday, April 29.

Pointstate Capital Lp, which manages about $10.76 billion and $11.77 billion US Long portfolio, decreased its stake in Sarepta Therapeutics Inc (NASDAQ:SRPT) by 230,922 shares to 401,000 shares, valued at $18.19M in 2017Q3, according to the filing. It also reduced its holding in Tesaro Inc (NASDAQ:TSRO) by 378,356 shares in the quarter, leaving it with 236,339 shares, and cut its stake in Alphabet Inc (Call).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts